Studies of ubiquinol in people
6 studies gave ubiquinol to people and measured what changed
| What changed | Design | People | Source |
|---|---|---|---|
up: Increases plasma CoQ10four times the placebo group no change: Has no effect on cognitive function no change: Has no effect on oxidative stress biomarkers | Randomized trial90 days | 111 people60 years and olderOlder adults; at study end versus placebo | Antioxidants (Basel, Switzerland), Jun 27, 2026 |
no change: Has no effect on oxidized LDL | Randomized trial12 weeks | 20 people18–60 yearsThai adults with prediabetes | BioMed research international, Mar 8, 2026 |
up: Improves flow-mediated dilation+1.28% ± 0.90% (200 mg/day), +1.34% ± 1.44% (100 mg/day) vs −0.41% ± 1.51% (placebo) | Randomized trial8 weeks | 51 peopleaged 35–65 yearsMen and post-menopausal women aged 35–65 years | Nutrients, Apr 15, 2020 |
no change: Has no effect on physical function down: Prevents coenzyme Q10 down: Decreases reactive oxygen species–37.4% and –35.5% | Randomized trial1 month | 21 peoplemales26 ± 5Healthy trained males | Redox report : communications in free radical research, Dec 1, 2018 |
down: Decreases alanine aminotransferase down: Decreases alkaline phosphatase | Randomized trial12 weeks | With simvastatin | Experimental biology and medicine (Maywood, N.J.), Sep 30, 2015 |
down: Decreases gamma-glutamyltransferasep < 0.001 no change: Has no effect on aspartate aminotransferase | Trial14-day | 53 peopleMen21-48 years of ageMidlife adults; General population; cohort II | BMC research notes, Jul 4, 2014 |